News Coverage 07.09.20 Share on Twitter Share on Facebook Share on LinkedIn How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease Related Announcement, Press Release Alliance Aims to Develop Next-Gen Cancer Therapies Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement, Press Release First Patients Dosed in Pancreatic Platform Trial